Epigenetic therapy is associated with similar survival compared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemia

We reviewed the outcome of 671 patients 65 years of age or older with newly diagnosed acute myeloid leukemia (AML) treated at our institution between 2000 and 2010 with intensive chemotherapy (n = 557) or azacitidine- or decitabine-based therapy (n = 114). Both groups were balanced according to cyto...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Quintás-Cardama, Alfonso, Ravandi, Farhad, Liu-Dumlao, Theresa, Brandt, Mark, Faderl, Stefan, Pierce, Sherry, Borthakur, Gautam, Garcia-Manero, Guillermo, Cortes, Jorge, Kantarjian, Hagop
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society of Hematology 2012
Θέματα:
Clinical Trials and Observations
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3952725/
https://ncbi.nlm.nih.gov/pubmed/23071272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-06-436055
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια